Skip to main content

Table 1 Patient’s characteristics - 3 Centers - (MitroFix© Device)

From: Mitral valve restoration using the No-React(R) MitroFix™: a novel concept

N valid
Age at surgery (mean)   51 67,58
    Range:52-
Gender   51  
  Males   32 (62,7%)
  Females   19 (37,3%)
Preoperative clinical status    
NYHA class   51  
  II   6 (11,8%)
  II-III   7 (13,7%)
  III   24 (47,1%)
  III-IV   6 (11,8%)
  IV   8 (15,7%)
Atrial fibrillation   51 21 (41,2%)
Additional cardiac diseases   51  
  None   20 (39,2%)
  Cardiac artery disease   18 (35,3%)
  Aortic valve disease   4 (7,8%)
  Tricuspid valve disease   13 (25,5%)
  Persistant foramen ovale   3 (5,9%)
  Redo   2 (3,9%)
  AAA   1 (2,0%)
Mitral regurgitation (preop)    
  III   17 (33,3%)
  III-IV   10 (19,6%)
  IV   24 (47,1%)